Photo by nci from unsplash
The paper by Robinson et al. [(1)][1] suggested that low-density lipoprotein cholesterol (LDL-C) values Click to show full abstract
The paper by Robinson et al. [(1)][1] suggested that low-density lipoprotein cholesterol (LDL-C) values <25 mg/dl were not associated with adverse neurocognitive events. The impact of lipid-lowering medication on cognitive function is an area of ongoing research with mixed evidence. A separate meta
Keywords:
cardiology;
risk adverse;
adverse neurocognitive;
pcsk inhibitors;
outcomes pcsk;
neurocognitive outcomes
Journal Title: Journal of the American College of Cardiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!